265 related articles for article (PubMed ID: 12909000)
1. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia.
Byrne BM; Crowley A; Taulo F; Anthony J; O'Leary JJ; O'Herlihy C
Hypertens Pregnancy; 2003; 22(2):157-64. PubMed ID: 12909000
[TBL] [Abstract][Full Text] [Related]
2. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
3. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
Tao H; Wang XM; Ji XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
[TBL] [Abstract][Full Text] [Related]
4. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
[TBL] [Abstract][Full Text] [Related]
5. Calprotectin plasma level is elevated in preeclampsia.
Holthe MR; Staff AC; Berge LN; Fagerhol MK; Lyberg T
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):151-4. PubMed ID: 15683375
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
Karina E; Tomasz P; Bilar M; Agnieszka O; Ewa B; Elzbieta RW
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
[TBL] [Abstract][Full Text] [Related]
7. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
8. Unmethylated-maspin DNA in maternal plasma is associated with severe preeclampsia.
Qi YH; Teng F; Zhou Q; Liu YX; Wu JF; Yu SS; Zhang X; Ma MY; Zhou N; Chen LJ
Acta Obstet Gynecol Scand; 2015 Sep; 94(9):983-8. PubMed ID: 26095742
[TBL] [Abstract][Full Text] [Related]
9. Serum androgen markers in preeclampsia.
Miller NR; Garry D; Cohen HW; Figueroa R
J Reprod Med; 2003 Apr; 48(4):225-9. PubMed ID: 12746983
[TBL] [Abstract][Full Text] [Related]
10. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.
Oron G; Ben-Haroush A; Hod M; Orvieto R; Bar J
Obstet Gynecol; 2006 Apr; 107(4):896-900. PubMed ID: 16582129
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
[TBL] [Abstract][Full Text] [Related]
12. Cell-free fetal DNA (SRY locus) concentration in maternal plasma is directly correlated to the time elapsed from the onset of preeclampsia to the collection of blood.
Farina A; Sekizawa A; Rizzo N; Concu M; Banzola I; Carinci P; Simonazzi G; Okai T
Prenat Diagn; 2004 Apr; 24(4):293-7. PubMed ID: 15065105
[TBL] [Abstract][Full Text] [Related]
13. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
Engel K; Płonka T; Bilar M; Czajkowska E; Orzińska E; Brojer E; Ronin-Walknowska E
Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
[TBL] [Abstract][Full Text] [Related]
14. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
Zhong XY; Laivuori H; Livingston JC; Ylikorkala O; Sibai BM; Holzgreve W; Hahn S
Am J Obstet Gynecol; 2001 Feb; 184(3):414-9. PubMed ID: 11228496
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of CA-125 in normal and preeclamptic pregnancies.
Ozat M; Kanat-Pektas M; Yenicesu O; Gungor T; Danisman N; Mollamahmutoglu L
Arch Gynecol Obstet; 2011 Sep; 284(3):607-12. PubMed ID: 21046132
[TBL] [Abstract][Full Text] [Related]
16. Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia.
Cotter AM; Martin CM; O'Leary JJ; Daly SF
BJOG; 2005 May; 112(5):584-7. PubMed ID: 15842281
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in peripheral blood cells of preeclamptic women.
Vuorela P; Lintula S; Stenman UH; Halmesmäki E
Hypertens Pregnancy; 2003; 22(2):193-201. PubMed ID: 12909004
[TBL] [Abstract][Full Text] [Related]
19. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.
Farina A; Sekizawa A; Sugito Y; Iwasaki M; Jimbo M; Saito H; Okai T
Prenat Diagn; 2004 Feb; 24(2):83-6. PubMed ID: 14974111
[TBL] [Abstract][Full Text] [Related]
20. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
